Truxima Approved as First Biosimilar to Non-Hodgkin's Lymphoma Drug
by Scott Roberts, Nov 28, 2018 at 2:39 PM • FDA Approvals
by Scott Roberts, Nov 28, 2018 at 2:39 PM • FDA Approvals
by Dennis Thompson, HealthDay Reporter, Oct 22, 2018 at 12:00 PM • News
by Robert Preidt, Sep 4, 2018 at 5:00 PM • News
by Robert Preidt, Aug 22, 2018 at 12:00 PM • News
by Robert Preidt, Aug 21, 2018 at 4:00 PM • News
by Scott Roberts, Aug 8, 2018 at 4:00 PM • FDA Approvals
by Robert Preidt, Jun 11, 2018 at 5:00 PM • News
by Scott Roberts, Mar 20, 2018 at 3:29 PM • FDA Approvals
by Serena Gordon, HealthDay Reporter, Jan 31, 2018 at 2:00 PM • News
by Robert Preidt, Jan 22, 2018 at 12:00 PM • News
by Robert Preidt, Dec 12, 2017 at 12:00 PM • News
by Scott Roberts, Oct 31, 2017 at 1:42 PM • FDA Approvals
by Robert Preidt, Oct 20, 2017 at 12:00 PM • News
Researchers say many doctors and patients may be unaware of the risk
by Scott Roberts, Oct 19, 2017 at 11:54 AM • FDA Approvals
The first such treatment for non-Hodgkin form of this cancer
by Amy Norton, HealthDay Reporter, Oct 4, 2017 at 5:00 PM • News
But blood cancer experts call for more research
Get the latest health news & tips via email, Mon‑Fri: